Bioequivalence and Bioavailability Forum • BE of racemic drugs (EMA’s practice)

BE of racemic drugs (EMA’s practice) [Regulatives / Guidelines]

posted by scorp2011 – India, 2012-01-16 14:08 (4482 d 18:03 ago) – Posting: # 7944
Views: 6,261

Dear HS,

Thanks for the details. Will update the details regarding outcome of the regulatory response.

Regards
Sonu

Complete thread:

Bioequivalence of racemic drugs using non-steriospecific bio scorp2011 2012-01-12 13:21 [Regulatives / Guidelines]
- BE of racemic drugs (EMA vs. FDA) Helmut 2012-01-12 19:21
  - BE of racemic drugs (EMA vs. FDA) scorp2011 2012-01-13 06:11
    - BE of racemic drugs (EMA’s practice) Helmut 2012-01-13 16:02
      - BE of racemic drugs (EMA’s practice)scorp2011 2012-01-16 13:08
        
        BE of racemic drugs (EMA’s practice) valivetiananth 2019-12-30 13:45
        
        BE of racemic drugs (EMA’s practice) Helmut 2019-12-30 14:35

Admin contact
22,993 posts in 4,828 threads, 1,657 registered users;
114 visitors (0 registered, 114 guests [including 2 identified bots]).
Forum time: 09:11 CEST (Europe/Vienna)

Never never never never use Excel.
Not even for calculation of arithmetic means. Martin Wolfsegger

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz